NO833257L - Farmasoeytisk preparat for hindring og behandling av ischemisk celleskade og fremgangsmaater for bruk og fremstilling derav - Google Patents

Farmasoeytisk preparat for hindring og behandling av ischemisk celleskade og fremgangsmaater for bruk og fremstilling derav

Info

Publication number
NO833257L
NO833257L NO833257A NO833257A NO833257L NO 833257 L NO833257 L NO 833257L NO 833257 A NO833257 A NO 833257A NO 833257 A NO833257 A NO 833257A NO 833257 L NO833257 L NO 833257L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
physiologically acceptable
solution
acid
water
Prior art date
Application number
NO833257A
Other languages
English (en)
Norwegian (no)
Inventor
Jan Lennart Hultman
Gunnar Ronquist
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of NO833257L publication Critical patent/NO833257L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO833257A 1982-01-18 1983-09-12 Farmasoeytisk preparat for hindring og behandling av ischemisk celleskade og fremgangsmaater for bruk og fremstilling derav NO833257L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8200252A SE8200252L (sv) 1982-01-18 1982-01-18 Farmaceutisk komposition

Publications (1)

Publication Number Publication Date
NO833257L true NO833257L (no) 1983-09-12

Family

ID=20345754

Family Applications (1)

Application Number Title Priority Date Filing Date
NO833257A NO833257L (no) 1982-01-18 1983-09-12 Farmasoeytisk preparat for hindring og behandling av ischemisk celleskade og fremgangsmaater for bruk og fremstilling derav

Country Status (8)

Country Link
EP (2) EP0085033A1 (da)
JP (1) JPS58502208A (da)
DK (1) DK421283D0 (da)
FI (1) FI833320A0 (da)
NO (1) NO833257L (da)
SE (1) SE8200252L (da)
WO (1) WO1983002391A1 (da)
ZA (1) ZA83130B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8403912D0 (sv) * 1984-07-30 1984-07-30 Pharmacia Ab Lekemedelssats eller -komposition
US4874882A (en) * 1986-03-25 1989-10-17 Ube Industries, Ltd. Process for preparing monosodium phosphoenolpyruvate
JP2930589B2 (ja) * 1986-10-06 1999-08-03 ザ ユニバーシィティ オブ バージニア アルミニ パテンツ ファンデーション 外科手術中における改善された心臓保護のためのアデノシン，ヒポキサンチン及びリボース含有溶液の使用
US5070877A (en) * 1988-08-11 1991-12-10 Medco Research, Inc. Novel method of myocardial imaging
JP2770175B2 (ja) * 1988-09-27 1998-06-25 科学技術振興事業団 腎臓の庇護液
JP2914454B2 (ja) * 1989-03-29 1999-06-28 メドコー・リサーチ・インコーポレイテッド 血管診断助剤
FR2684381B1 (fr) * 1991-12-03 1995-05-05 Nicole Bru Composes presentant une liaison amide phosphorique ou une liaison phosphate d'enol pour leur application en tant que substance therapeutiquement active.
DE19603053A1 (de) * 1996-01-29 1997-07-31 Bayer Ag Verfahren zur Herstellung von Polymeren mit wiederkehrenden Succinyl-Einheiten
GB9624188D0 (en) * 1996-11-21 1997-01-08 Itc Research Limited Pharmaceutical formulations
JPWO2008038417A1 (ja) * 2006-09-28 2010-01-28 興和株式会社 循環器官用薬
TW200824676A (en) * 2006-10-24 2008-06-16 Kowa Co Cardiovascular drug

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1083911A (en) * 1964-01-13 1967-09-20 Chugai Pharmaceutical Co Ltd Adenosine triphosphate salts of l-ornithine and process for preparing the same
FR3246M (fr) * 1964-02-06 1965-04-12 Pharmacodynamie Et Metabolisme Médicaments a base d'acide phospho-énol-pyruvique.
DE1939008A1 (de) * 1969-07-31 1971-02-11 Zander Dr Helmut Arzneimittelkombination zur Behandlung von Mangeldurchblutungen des Gehirns
US4216211A (en) * 1977-10-31 1980-08-05 The Procter & Gamble Company Therapeutic composition

Also Published As

Publication number Publication date
DK421283A (da) 1983-09-15
ZA83130B (en) 1983-10-26
EP0098853A1 (en) 1984-01-25
WO1983002391A1 (en) 1983-07-21
DK421283D0 (da) 1983-09-15
JPS58502208A (ja) 1983-12-22
FI833320L (fi) 1983-09-16
FI833320A7 (fi) 1983-09-16
SE8200252L (sv) 1983-07-19
FI833320A0 (fi) 1983-09-16
EP0085033A1 (en) 1983-08-03

Similar Documents

Publication Publication Date Title
US4605644A (en) Method for stimulating recovery from ischemia employing ribose and adenine
Clowes Jr et al. Circulatory and metabolic alterations associated with survival or death in peritonitis: clinical analysis of 25 cases
Fernando et al. Enhanced preservation of the ischaemic kidney with inosine
US6986905B1 (en) Pharmaceutical compositions for treating and saving and the method for the preparation thereof
ES2450131T3 (es) Soluciones de diálisis esterilizadas que contienen pirofosfato
NO833257L (no) Farmasoeytisk preparat for hindring og behandling av ischemisk celleskade og fremgangsmaater for bruk og fremstilling derav
CN102421431A (zh) 包含一或多种肌酸化合物的血液透析和腹膜透析溶液
JP2859319B2 (ja) イノシトールトリホスフェートを含有する移植に関する障害に対する医薬
EP0590514A1 (en) Blood preserving composition and method for preserving blood
Ginther et al. Use of del Nido cardioplegia solution and a low-prime recirculating cardioplegia circuit in pediatrics
US5944020A (en) Use of fructose-1 6-diphosphate as an inotrope drug after cardiopulmonary bypass surgery
Kofsky et al. Studies of myocardial protection in the immature heart: V. Safety of prolonged aortic clamping with hypocalcemic glutamate/aspartate blood cardioplegia
EP0188595A1 (en) A drug kit or drug composition for use in preventing and treating ischaemic cell damage and preparation thereof
Materson Insights into intrarenal sites and mechanisms of action of diuretic agents
US8563233B2 (en) Blood substitute solution
Hasselgren et al. Failure of an increased dose of ATP-MgCl2 to improve protein synthesis and transmembrane potential in the postischemic liver
JP6629850B2 (ja) 汎用心停止液（変種）
Franco et al. Effects of reperfusion after acute coronary occlusion on the beating, working heart compared to the arrested heart treated locally and globally with cardioplegia
KR20060128972A (ko) 적혈구 기능 수식 물질
US11185574B2 (en) Protective solution for preventing or reducing reperfusion injury of the brain and the whole body
Ihnken et al. Reversal by controlled limb reperfusion: a case report
Bloomfield et al. A prospective trial of diaspirin cross-linked hemoglobin solution in patients after elective repair of abdominal aortic aneurysm
Sugishita et al. Decreased reactive hyperemia after coronary perfusion with nonoxygenated solution
EP0695185B1 (en) Use of adenosine for the manufacture of a medicament for the treatment of pulmonary inflammatory reactions
Yamagishi et al. Effects of three purine‐related compounds on pancreatic exocrine secretion in the dog